GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » High Tech Pharm Co Ltd (XKRX:106190) » Definitions » EV-to-Revenue

High Tech Pharm Co (XKRX:106190) EV-to-Revenue : 1.66 (As of Jun. 03, 2025)


View and export this data going back to 2010. Start your Free Trial

What is High Tech Pharm Co EV-to-Revenue?

EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, High Tech Pharm Co's enterprise value is ₩121,911 Mil. High Tech Pharm Co's Revenue for the trailing twelve months (TTM) ended in Mar. 2025 was ₩73,578 Mil. Therefore, High Tech Pharm Co's EV-to-Revenue for today is 1.66.

The historical rank and industry rank for High Tech Pharm Co's EV-to-Revenue or its related term are showing as below:

XKRX:106190' s EV-to-Revenue Range Over the Past 10 Years
Min: 0.8   Med: 1.46   Max: 2.96
Current: 1.66

During the past 13 years, the highest EV-to-Revenue of High Tech Pharm Co was 2.96. The lowest was 0.80. And the median was 1.46.

XKRX:106190's EV-to-Revenue is ranked better than
63.41% of 973 companies
in the Drug Manufacturers industry
Industry Median: 2.43 vs XKRX:106190: 1.66

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

As of today (2025-06-03), High Tech Pharm Co's stock price is ₩12180.00. High Tech Pharm Co's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2025 was ₩6,910.47. Therefore, High Tech Pharm Co's PS Ratio for today is 1.76.


High Tech Pharm Co EV-to-Revenue Historical Data

The historical data trend for High Tech Pharm Co's EV-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

High Tech Pharm Co EV-to-Revenue Chart

High Tech Pharm Co Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
EV-to-Revenue
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1.88 1.37 0.83 1.01 1.92

High Tech Pharm Co Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
EV-to-Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.33 2.17 1.76 1.92 1.94

Competitive Comparison of High Tech Pharm Co's EV-to-Revenue

For the Drug Manufacturers - Specialty & Generic subindustry, High Tech Pharm Co's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


High Tech Pharm Co's EV-to-Revenue Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, High Tech Pharm Co's EV-to-Revenue distribution charts can be found below:

* The bar in red indicates where High Tech Pharm Co's EV-to-Revenue falls into.


;
;

High Tech Pharm Co EV-to-Revenue Calculation

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

High Tech Pharm Co's EV-to-Revenue for today is calculated as:

EV-to-Revenue=Enterprise Value (Today)/Revenue (TTM)
=121911.238/73578.001
=1.66

High Tech Pharm Co's current Enterprise Value is ₩121,911 Mil.
High Tech Pharm Co's Revenue for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was ₩73,578 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


High Tech Pharm Co  (XKRX:106190) EV-to-Revenue Explanation

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

High Tech Pharm Co's PS Ratiofor today is calculated as:

PS Ratio=Share Price (Today)/Revenue per Share (TTM)
=12180.00/6910.474
=1.76

High Tech Pharm Co's share price for today is ₩12180.00.
High Tech Pharm Co's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was ₩6,910.47.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


High Tech Pharm Co EV-to-Revenue Related Terms

Thank you for viewing the detailed overview of High Tech Pharm Co's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


High Tech Pharm Co Business Description

Traded in Other Exchanges
N/A
Address
576-1, Seongbon-Ri, Daeso-Myeon, Eumseong, North Chungcheong, KOR, 369-823
High Tech Pharm Co Ltd manufactures and markets medicines. The company focuses on active pharmaceutical ingredients of antibiotics.

High Tech Pharm Co Headlines

No Headlines